GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
8DLY | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) | |
8DLZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 | |
8DM0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) | |
8DZH | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8DZI | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
7XRP | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) | |
8BSE | P0DTC2 | CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD) in complex with 1D1 Fab | |
8BSF | P0DTC2 | CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD-beta variant) in complex with 3D2 Fab | |
8CSJ | P0DTC2 | Cryo-EM structure of NTD-directed non-neutralizing antibody 4-33 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
8HN7 | P0DTC2 | Crystal structure of monoclonal antibody complexed with SARS-CoV-2 RBD | |
8IF2 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein in complex with its receptor ACE2 | |
7WT7 | P0DTC2 | SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 1) | |
7WT8 | P0DTC2 | SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 2) | |
7Y6D | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Delta variant spike proteins on intact virions: 3 Closed RBD | |
8D55 | P0DTC2 | Closed state of SARS-CoV-2 BA.2 variant spike protein | |
8D56 | P0DTC2 | One RBD-up state of SARS-CoV-2 BA.2 variant spike protein | |
8D5A | P0DTC2 | Middle state of SARS-CoV-2 BA.2 variant spike protein | |
8DT8 | P0DTC2 | LM18/Nb136 bispecific tetra-nanobody immunoglobulin in complex with SARS-CoV-2-6P-Mut7 S protein (focused refinement) | |
8EOO | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibodies WRAIR-2063 and WRAIR-2151 | |
7XY3 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with VHH14 | |
7XY4 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with VHH21 | |
7Y0N | P0DTC2 | SARS-CoV-2 WT Spike in complex with R15 Fab and P14 Nanobody | |
8F0I | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody COVA309-22 | |
8P99 | P0DTC2 | SARS-CoV-2 S-protein:D614G mutant in 1-up conformation | |
8P9Y | P0DTC2 | SARS-CoV-2 S protein S:D614G mutant in 3-down with binding site of an entry inhibitor | |
8OWT | P0DTC2 | SARS-CoV-2 spike RBD with A8 and H3 nanobodies bound | |
8OWV | P0DTC2 | H6 and F2 nanobodies bound to SARS-CoV-2 spike RBD | |
8OWW | P0DTC2 | B5-5 nanobody bound to SARS-CoV-2 spike RBD (Wuhan) | |
8QRF | P0DTC2 | SARS-CoV-2 delta RBD complexed with XBB-6 and beta-49 Fabs | |
8QRG | P0DTC2 | SARS-CoV-2 delta RBD complexed with XBB-2 Fab and NbC1 | |
8QSQ | P0DTC2 | Locally refined SARS-CoV-2 BA-2.86 Spike receptor binding domain (RBD) complexed with angiotensin converting enzyme 2 (ACE2) | |
8ZC2 | P0DTC2 | SARS-CoV-2 Omicron BA.2 spike trimer (6P) in complex with D1F6 Fab, head-to-head aggregate | |
8ZC6 | P0DTC2 | SARS-CoV-2 Omicron BA.4 spike trimer (6P) in complex with D1F6 Fab, head-to-head aggregate | |
8QH0 | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD with the antibody Cv2.3194 | |
8UKD | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.5) | |
8UKF | P0DTC2 | SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-EG.5) | |
7FJN | P0DTC2 | Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab | |
7FJS | P0DTC2 | Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351 | |
7SD5 | P0DTC2 | Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain | |
7SI2 | P0DTC2 | Crystal structure of neutralizing antibody 10-28 in complex with SARS-CoV-2 spike receptor binding domain (RBD) | |
7UAP | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520 | |
7UAQ | P0DTC2 | Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement | |
7UAR | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717 | |
7X7N | P0DTC2 | 3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5. | |
7F12 | P0DTC2 | A SARS-CoV-2 neutralizing antibody | |
7F15 | P0DTC2 | A SARS-CoV-2 neutralizing antibody | |
7FCP | P0DTC2 | Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) | |
7FCQ | P0DTC2 | Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) | |
7VRV | P0DTC2 | VAS5 Spike (1 RBD up) | |
7VRW | P0DTC2 | VAS5 Spike (3 RBD down) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024